Leukemia Quiz
Test your knowledge about the types, symptoms, and treatments of leukemia, a cancer of the blood-forming tissues.
Leukemia: Practice Guide for Exam-Style Questions
Understanding leukemia requires grasping its core classifications, key diagnostic markers, and clinical presentations. This guide breaks down essential concepts to help you navigate exam questions about this complex hematologic malignancy.
Defining Leukemia: The Core Concept
Leukemia is a cancer of the body’s blood-forming tissues, primarily the bone marrow and lymphatic system. It is characterized by the overproduction of abnormal, immature white blood cells (leukocytes). These malignant cells crowd out healthy blood cells, leading to a trio of common problems: anemia, infection, and bleeding.
Acute vs. Chronic Leukemia: The Pace of Progression
This is a fundamental distinction. Acute leukemias involve immature cells (blasts), progress rapidly, and are life-threatening without immediate treatment. Chronic leukemias involve more mature-appearing cells, progress slowly over years, and may be discovered incidentally on routine blood work.
Lymphoid vs. Myeloid Leukemia: The Cell of Origin
The second major classification is the cell lineage. Lymphoid leukemias arise from the lymphoid cell line, which produces lymphocytes (B-cells, T-cells). Myeloid leukemias arise from the myeloid cell line, which produces red blood cells, platelets, and other types of white cells like neutrophils and monocytes.
Key Subtypes: ALL, AML, CLL, and CML
Combining these classifications gives you the four main types. For exams, know the most common patient demographic for each:
- Acute Lymphoblastic Leukemia (ALL): Most common cancer in children.
- Acute Myeloid Leukemia (AML): More common in adults, with incidence increasing with age.
- Chronic Lymphocytic Leukemia (CLL): Most common leukemia in adults in Western countries, typically affecting older adults.
- Chronic Myeloid Leukemia (CML): Primarily affects adults.
Pathognomonic Findings: Auer Rods and Philadelphia Chromosome
Certain microscopic or genetic findings are classic clues in test questions. Auer rods, which are needle-like inclusions in the cytoplasm of blast cells, are pathognomonic for AML. The Philadelphia chromosome, a translocation between chromosomes 9 and 22, is the hallmark of CML.
Memory Aid: Think “Auer rods for AML” and remember the city of “Philadelphia” is known for its CML (Chronic Myeloid Leukemia) treatment advances.
Common Clinical Presentations and Symptoms
Symptoms stem from bone marrow failure due to overcrowding by cancer cells (cytopenias). Be prepared to identify symptoms related to each cell line deficiency:
- Anemia (low red blood cells): Fatigue, weakness, pallor, shortness of breath.
- Thrombocytopenia (low platelets): Easy bruising, petechiae, frequent nosebleeds, bleeding gums.
- Neutropenia (low neutrophils): Recurrent or severe infections, fever.
- Leukemic Infiltration: Bone pain, swollen lymph nodes, enlarged spleen or liver.
Essential Diagnostic Workup
While a complete blood count (CBC) with differential is the initial screening test that raises suspicion, it is not definitive. The gold standard for confirming a leukemia diagnosis and determining the specific subtype is a bone marrow aspiration and biopsy. This allows for morphological, immunophenotypic, and cytogenetic analysis.
Principles of Leukemia Treatment
Treatment goals vary widely. For acute leukemias, the aim is a cure, starting with aggressive induction chemotherapy to achieve remission. For chronic leukemias, the goal is often long-term disease control. CML, for example, is managed highly effectively with targeted therapy (tyrosine kinase inhibitors).
Key Takeaways for Review
- Leukemia is a cancer of blood-forming tissues defined by abnormal white blood cell proliferation.
- The primary classification is based on acuity (acute/chronic) and cell lineage (myeloid/lymphoid).
- Acute leukemias (AML, ALL) feature immature “blasts,” have a rapid onset, and require immediate, intensive therapy.
- Chronic leukemias (CML, CLL) involve more mature cells, progress slowly, and may be managed with targeted therapies or observation.
- Memorize the key markers: Auer rods are definitive for AML, and the Philadelphia chromosome is the hallmark of CML.
Frequently Asked Questions
What is the difference between leukemia and lymphoma?
Leukemia primarily involves the bone marrow and blood (“liquid tumor”), while lymphoma primarily involves the lymph nodes and lymphatic system (“solid tumor”). However, there can be overlap, as some lymphomas can spread to the bone marrow.
Why is a bone marrow biopsy necessary if the CBC is abnormal?
A CBC can only suggest leukemia by showing abnormal cell counts and blasts in the peripheral blood. A bone marrow biopsy is essential to confirm the diagnosis, determine the percentage of blasts, and perform genetic tests to identify the exact subtype, which dictates the treatment plan.
What does “remission” mean in the context of leukemia?
Complete remission means there is no evidence of leukemia cells in the bone marrow (typically <5% blasts), and normal blood counts have returned. It is the initial goal of therapy but is not the same as a cure, as microscopic residual disease may still be present.
What is the role of targeted therapy in CML?
Targeted therapy, specifically tyrosine kinase inhibitors (TKIs) like imatinib, has revolutionized CML treatment. These drugs block the abnormal protein created by the BCR-ABL gene (from the Philadelphia chromosome), stopping the cancer cells from growing and dividing.
What is a “blast crisis” in CML?
A blast crisis is a late, acute phase of Chronic Myeloid Leukemia where the disease transforms into a state resembling an acute leukemia. The number of blast cells in the blood and bone marrow increases dramatically, and the condition becomes much more aggressive and difficult to treat.
What is Tumor Lysis Syndrome (TLS)?
TLS is a potential emergency that can occur at the start of chemotherapy for fast-growing cancers like acute leukemia. As cancer cells are rapidly killed, they release their contents (potassium, phosphate, nucleic acids) into the blood, which can cause severe metabolic disturbances and kidney failure if not managed proactively.
This content is for informational and educational purposes only. It is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of a qualified health provider with any questions you may have regarding a medical condition.

I am a Registered Pharmacist under the Pharmacy Act, 1948, and the founder of PharmacyFreak.com. I hold a Bachelor of Pharmacy degree from Rungta College of Pharmaceutical Science and Research. With a strong academic foundation and practical knowledge, I am committed to providing accurate, easy-to-understand content to support pharmacy students and professionals. My aim is to make complex pharmaceutical concepts accessible and useful for real-world application.
Mail- Sachin@pharmacyfreak.com